Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

793 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial.
Puig L, Costanzo A, de Jong EMGJ, Torres T, Warren RB, Wapenaar R, Wegner S, Gorecki P, Gramiccia T, Jazra M, Buyze J, Conrad C. Puig L, et al. Among authors: costanzo a. Am J Clin Dermatol. 2024 Mar;25(2):315-325. doi: 10.1007/s40257-023-00816-1. Epub 2023 Oct 7. Am J Clin Dermatol. 2024. PMID: 37804472 Free PMC article.
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study.
Stingeni L, Malara G, Conti A, Di Costanzo L, Carrera CG, Burlando M, Malagoli P, Musumeci ML, Bardazzi F, Brazzelli V, Amerio P, De Simone C, Trevisini S, Balato A, Megna M, Loconsole F, De Felice C, Bartezaghi M, Rausa A, Aloisi E, Orsenigo R, Costanzo A; SUPREME Study Group. Stingeni L, et al. Among authors: costanzo a. Clin Cosmet Investig Dermatol. 2023 Jan 5;16:27-38. doi: 10.2147/CCID.S378135. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 36636635 Free PMC article.
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.
Talamonti M, Russo F, Malara G, Hansel K, Papini M, Cattaneo A, Parodi A, Chiricozzi A, Malagoli P, Bardazzi F, Brazzelli V, Dapavo P, Gisondi P, Zane C, Potenza C, Cantoresi F, Fargnoli MC, Trevisini S, Brianti P, Pescitelli L, Gigante G, Bartezaghi M, Caputo L, Aloisi E, Costanzo A; SUPREME Study Group. Talamonti M, et al. Among authors: costanzo a. Clin Cosmet Investig Dermatol. 2023 Apr 1;16:847-852. doi: 10.2147/CCID.S400520. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37033782 Free PMC article.
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases.
Vetrano S, Bouma G, Benschop RJ, Birngruber T, Costanzo A, D'Haens GRAM, Frasca L, Hillenbrand R, Iversen L, Johansen C, Kaser A, Koenen HJPM, Noehammer C, Peyrin-Biroulet L, Raes J, Ricotti L, Rosenstiel P, Satagopam VP, Schreiber S, Vermeire S, Wollenberg A, Weidinger S, Ziemek D, Danese S; ImmUniverse Consortium. Vetrano S, et al. Among authors: costanzo a. Front Immunol. 2022 Nov 9;13:1002629. doi: 10.3389/fimmu.2022.1002629. eCollection 2022. Front Immunol. 2022. PMID: 36439150 Free PMC article.
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO).
Pinter A, Costanzo A, Khattri S, Smith SD, Carrascosa JM, Tada Y, Riedl E, Reich A, Brnabic A, Haustrup N, Lampropoulou A, Lipkovich I, Kadziola Z, Paul C, Schuster C. Pinter A, et al. Among authors: costanzo a. Dermatol Ther (Heidelb). 2023 Dec 19. doi: 10.1007/s13555-023-01086-9. Online ahead of print. Dermatol Ther (Heidelb). 2023. PMID: 38113010
Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals.
Paolino G, Narcisi A, Carugno A, Malagoli P, Di Nicola MR, Foti A, Bianchi VG, Locatelli AG, Sena P, Costanzo A, Mercuri SR, Valenti M. Paolino G, et al. Among authors: costanzo a. J Dermatolog Treat. 2024 Dec;35(1):2351489. doi: 10.1080/09546634.2024.2351489. Epub 2024 May 9. J Dermatolog Treat. 2024. PMID: 38724042 Free article.
The Combination of Dupilumab with Other Monoclonal Antibodies.
Gisondi P, Maurelli M, Costanzo A, Esposito M, Girolomoni G. Gisondi P, et al. Among authors: costanzo a. Dermatol Ther (Heidelb). 2023 Jan;13(1):7-12. doi: 10.1007/s13555-022-00851-6. Epub 2022 Nov 10. Dermatol Ther (Heidelb). 2023. PMID: 36355314 Free PMC article.
793 results